RN
RIEDEL NORBERT G Director
OFFICER M
US US · SEC (Form 4)
€394,523
▲ Purchases (2 ops.)
Explore the full record of transactions filed by RIEDEL NORBERT G, Director. Officer active across 5 companies, notably Eton Pharmaceuticals, Inc.. Cumulatively, 16 filings have been published. Total volume traded: €721k. The latest transaction was filed on 21 April 2026 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 16 total
US$77,804 12,500 shares @ US$6.2243 0.0094% mcap 40.9% of flow
Common Stock
SEC:0001437749-26-013041 · 21 Apr 2026
€77,804 12,500 shares @ €6.2243 0.0094% mcap 20.5% of flow
Common Stock
SEC:0001437749-26-013041:0 · 21 Apr 2026
US$112,385 30,000 shares @ US$3.7462 0.014% mcap 59.1% of flow
Common Stock
SEC:0001437749-26-003230 · 3 Feb 2026
€112,385 30,000 shares @ €3.7462 0.014% mcap 29.5% of flow
Common Stock
SEC:0001437749-26-003230:0 · 3 Feb 2026
14,270 shares
Common Stock
SEC:0000899243-22-001199 · 4 Jan 2022
14,270 shares
Common Stock
SEC:0000899243-22-001199:0 · 4 Jan 2022
€197,261 100,000 shares @ €1.9726 100.0% of flow
Common Stock
SEC:0001415889-21-005779 · 6 Dec 2021
Ideal exit: 2 Sept 2022 (T+270) €197,261 100,000 shares @ €1.9726 50.0% of flow
Common Stock
SEC:0001415889-21-005779:0 · 6 Dec 2021
Ideal exit: 2 Sept 2022 (T+270) €163,265 1,306 shares @ €125.0114 0.0011% mcap 100.0% of flow
Ordinary Shares
SEC:0001765581-21-000108 · 6 Aug 2021
€163,265 1,306 shares @ €125.0114 0.0011% mcap 50.0% of flow
Ordinary Shares
SEC:0001765581-21-000108:0 · 6 Aug 2021
02,246 shares 0
Ordinary Shares
SEC:0001765581-21-000081 · 29 Jul 2021
02,246 shares 0
Ordinary Shares
SEC:0001765581-21-000081:0 · 29 Jul 2021
0380,000 shares 0
Common Stock
SEC:0001415889-21-002619 · 17 May 2021
0380,000 shares 0
Common Stock
SEC:0001415889-21-002619:0 · 17 May 2021
0380,000 shares 0
Common Stock
SEC:0001415889-21-002573 · 17 May 2021
0380,000 shares 0
Common Stock
SEC:0001415889-21-002573:0 · 17 May 2021
About RIEDEL NORBERT G Norbert G. Riedel is a director at Eton Pharmaceuticals, Inc.